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Abstract
Introduction:  Papillary  carcinoma  is  the  most  common  malignant  thyroid  neoplasm.  The  effect
of the  concurrent  presence  of  Hashimoto’s  thyroiditis  and  papillary  thyroid  carcinoma  remains
controversial.
Objective:  To  evaluate  the  association  between  Hashimoto’s  thyroiditis  and  clinicopathological
parameters  in  thyroid  papillary  carcinoma  cases,  based  on  an  historical  institutional  cohort
analysis.
Methods: Cross-sectional  study  obtained  from  a  historical  cohort,  including  all  cases  submitted
to thyroidectomy  for  papillary  thyroid  carcinoma  in  a  single  institution  during  an  11-year  period
study.
Results: A  total  of  417  patients  with  papillary  thyroid  carcinoma  were  enrolled;  148  (35.4%)  also
had Hashimoto’s  thyroiditis.  A  female  predominance  among  cases  associated  to  Hashimoto’s
thyroiditis  was  observed.  The  thyroid  tumor,  in  cases  associated  with  Hashimoto’s  thyroidi-
tis, had  a  smaller  mean  diameter,  lower  frequency  of  extra-thyroid  extension,  and  earlier
clinicopathological  staging.
Conclusions:  A  high  proportion  of  papillary  thyroid  carcinoma  cases  are  associated  with
Hashimoto’s  thyroiditis.  There  are  associations  among  these  cases  with  several  histopatholog-
ical factors  already  recognized  for  their  prognostic  value,  which  by  themselves  could  impact
outcomes.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
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Carcinoma  papilífero  da  tireoide:  a  associac¸ão  com  tireoidite  de  Hashimoto  inﬂuencia
nas  características  clínico-patológicas  da  doenc¸a?
Resumo
Introduc¸ão:  O  carcinoma  papilífero  é  a  neoplasia  maligna  mais  comum  da  tireóide.  O  efeito  da
coexistência  da  tireoidite  de  Hashimoto  (TH)  no  prognóstico  do  carcinoma  papilífero  da  tireóide
(CPT) permanece  controverso.
Objetivo:  Avaliar  a  associac¸ão  entre  TH  e  parâmetros  clínico-patológicos  entre  pacientes  com
diagnóstico  de  carcinoma  papilífero  da  tireóide  obtidos  através  da  análise  de  uma  série  histórica
institucional.
Método: Coorte  transversal  com  base  em  uma  coorte  histórica,  envolvendo  todos  os  casos
submetidos  à  tireoidectomia  total  por  motivo  de  carcinoma  papilífero,  realizadas  na  mesma
Instituic¸ão ao  longo  de  11  anos.
Resultados:  Um  total  de  417  pacientes  foram  incluídos  no  estudo,  estando  148  (35,4%)  associa-
dos à  TH.  Observamos  preponderância  de  mulheres  entre  os  casos  associados  à  TH.  Esses  casos  se
apresentaram  com  menor  média  de  diâmetro  tumoral,  menor  frequência  de  comprometimento
extra-tireoidiano  e  estadiamento  clínico-patológico  mais  precoce.
Conclusões:  Um  percentual  expressivo  de  casos  de  CPT  apresenta-se  associado  à  TH.  A
associac¸ão entre  esses  casos,  com  vários  fatores  histopatológicos  já  reconhecidos  por  seu  valor
prognóstico,  pode  por  sí  só  inﬂuenciar  no  desfecho  desses  pacientes.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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apillary  thyroid  carcinoma  (PTC)  and  Hashimoto’s  thyroidi-
is  (HT)  are  common  diseases  in  clinical  practice.  Papillary
arcinoma  is  the  most  common  malignant  neoplasm  of  the
hyroid.  HT  is  the  most  prevalent  autoimmune  disease  and
ne  of  the  most  common  endocrine  diseases.1 This  condi-
ion  is  the  most  common  cause  of  hypothyroidism,  excluding
ases  secondary  to  thyroidectomy,  that  are  predominant
mong  females.2 The  association  between  PTC  and  HT  was
rst  described  in  1955  by  Dailey  et  al.,3 and  became  evident
ecause  of  an  increase  in  new  cases  of  thyroiditis  diag-
osed  by  anatomopathological  exams  over  the  past  decades.
he  concept  of  chronic  inﬂammation  as  a  risk  factor  for
he  development  of  malignancies  has  been  well  established
or  other  tumors.  However,  with  respect  to  these  two  enti-
ies,  the  association  of  cause  and  effect  between  them
emains  uncertain.4 Both  diseases  may  have  a  subclinical
ourse  and  may  be  merely  an  incidental  diagnosis.  Most
ublications  on  the  subject  are  based  on  historical  reviews
f  series  of  patients  undergoing  thyroidectomy,  or  on  large
xploratory  studies  among  patients  who  underwent  ﬁne  nee-
le  aspiration  (FNA).4 The  results  now  available  do  not  allow
eﬁnitive  conclusions,  although  the  evidence  that  nonspe-
iﬁc  focal  or  multifocal  lymphocytic  inﬁltrates  may  also
ccur  more  frequently  in  cases  of  PTC  suggests  that  the
umor  can  exert  some  degree  of  inﬂuence  on  the  rest  of
he  gland.1
Some  authors  have  reported  that  the  presence  of  HT  in
atients  with  PTC  is  associated  with  a  less  aggressive  clini-
al  presentation  and  course.5--7 However,  other  studies  have
ot  found  similar  effects.8--10 The  objective  of  this  study
as  to  investigate  a  large  institutional  series  of  patients
ith  PTC  noting  the  prevalence  of  an  association  of  HT
c
C
cnd,  comparing  clinicopathological  characteristics  of  PTC
atients  with  or  without  an  associated  HT.
ethods
atients
he  histopathological  records  of  all  patients  who  under-
ent  total  thyroidectomy  at  this  institution  with  a  ﬁnal
istopathological  diagnosis  of  PTC  from  June  of  2000  to
ecember  of  2010  were  reviewed.  Of  623  cases  of  thyroidec-
omy  due  to  thyroid  cancer  conducted  in  the  period,  417
66.97%)  met  the  inclusion  criteria.  All  patients  underwent
linical  and  ultrasonographic  evaluation  in  the  preoperative
eriod.  Relevant  cases  underwent  cytologic  evaluation  of
hyroid  nodules  by  FNA.  Neck  dissection  procedures  in  the
entral  or  lateral  compartment  are  not  performed  electively
t  this  institution,  but  rather  are  reserved  for  cases  with
linical  or  ultrasonographic  evidence  of  lymph  node  metas-
ases.  Patients  with  nonspeciﬁc  focal  (16  cases)  or  multifocal
40  cases)  thyroiditis,  cases  of  thyroid  disease  due  to  Graves’
isease  (two  cases)  or  xanthogranulomatous  inﬂammation
four  cases),  cases  submitted  to  partial  thyroidectomy  (60
ases),  cases  with  more  than  one  tumor  histology  in  the
ame  gland  (two  synchronous  cases  of  papillary  and  follicu-
ar  carcinoma,  and  one  synchronous  case  of  papillary  and
edullary  carcinoma),  and  cases  with  no  information  on
umoral  diameter  (19  cases)  were  excluded  from  the  analy-
is.The  following  parameters  were  entered  into  a  dedi-
ated  database  (Microsoft  Excel® 2003  version;  Microsoft
orporation  --  Redmond,  WA,  United  States):  age,  gender,
oncomitant  HT,  association  with  lymph  node  dissection,
es  
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detailed  histopathological  description,  predominant  nod-
ule  diameter,  multifocality,  multicentricity,  extra-thyroid
extension,  T,  N,  and  M  staging,  and  clinicopathological  stag-
ing.
Deﬁnitions  and  pathology
In  this  study,  tumors  were  considered  multifocal  when  two  or
more  foci  were  found  in  the  same  lobe  of  the  gland.  Tumors
were  considered  multicentric  when  the  presence  of  more
than  one  tumor  focus  in  different  lobes  of  the  gland  was
found.  The  diagnosis  of  HT  was  based  on  histopathological
ﬁndings.  According  to  the  study  of  Mizukami  et  al.,11 only
cases  with  an  association  of  lymphoplasmacytic  inﬁltration
with  germinative  center  formation,  oxyphilic  cell  meta-
plasia  (Hürtle),  atrophy,  and  ﬁbrosis  of  thyroid  follicles12
(also  called  signs  of  chronic  oxyphilic  lymphocytic  thy-
roiditis)  were  classiﬁed  as  HT.  Papillary  microcarcinomata
were  deﬁned  as  tumors  with  diameter  ≤1.0  cm  at  histologi-
cal  examination.  The  clinicopathological  staging  procedures
were  performed  according  to  the  American  Joint  Commit-
tee  on  Cancer  TNM  staging  system  (7th  Edition).13 The  lymph
node  status  was  deﬁned  by  pathological  evidence  of  metas-
tasis  in  the  lymph  nodes  that  were  removed.  Extra-glandular
involvement  was  determined  based  on  evidence  of  tumor
inﬁltrates  beyond  the  gland  capsule,  at  microscopic  exam-
ination.  All  data  were  collected  by  the  same  researcher
(Girardi  FM)  and  all  pathologic  reviews  were  performed  by
the  same  pathologist  (Barra  MB).
Statistical  analysis  and  ethical  aspects
Descriptive  analysis  was  used  to  summarize  data.  The
Kolmogorov--Smirnov  test  was  performed  to  assess  the  nor-
mality  of  continuous  variables.  Continuous  variables  with
normal  distribution  were  expressed  as  means  and  standard
deviations.  Those  with  non-normal  distribution  were  also
expressed  as  median  and  minimum--maximum  values.  Cat-
egorical  variables  were  expressed  as  absolute  and  relative
frequency.  Student’s  t-test  was  used  to  compare  means  of
age,  the  Mann--Whitney  U  test  to  compare  tumor  size,  and
the  non-parametric  chi-squared  test  for  the  comparison  of
categorical  variables.  This  statistical  analysis  was  performed
using  SPSS  software  version  15.0  (SPSS  Inc.  --  Chicago,  IL,
United  States).  All  tests  considered  a  signiﬁcance  level  of
5%.
The  authors  guarantee  the  preservation  of  data  and  the
conﬁdentiality  of  the  material  obtained.  As  no  interventions
were  performed,  an  informed  consent  did  not  apply.  This
project  was  approved  by  the  research  ethics  committee  of
this  institution  (Project  No.  3483/11).
Results
A  total  of  417  cases  were  included  in  this  study,  compris-
ing  66.97%  of  the  cases  submitted  to  thyroidectomy  for
cancer  at  the  institution  from  2000  to  2010.  Of  this  total,
339  (81.2%)  were  women.  The  male:female  ratio  was  1:4.3.
The  mean  age  was  46.73  (12.14)  years,  ranging  from  13  to
87  years.  In  148  (35.4%)  cases,  the  patient  harbored  PTC
together  with  HT.  A  statistically  signiﬁcant  association  of
a
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TC  with  HT  was  observed,  when  compared  to  other  histo-
ogical  subtypes  (p  <  0.001).  Patients  with  coexisting  PTC  and
T  presented  at  an  earlier  clinicopathological  stage  and  with
 lower  rate  of  extra-glandular  involvement  (Table  1).  There
as  a predominance  of  females  among  cases  associated  with
hyroiditis.  This  study  did  not  observe  statistically  signiﬁ-
ant  differences  in  the  variable  ‘‘age’’  between  groups,  nor
ith  respect  to  multifocality,  multicentricity,  neurovascular
nvasion,  and  M  staging.  Similarly,  no  signiﬁcant  difference
as  found  with  respect  to  N  staging,  despite  the  higher
requency  of  cervical  lymphadenectomy  in  the  group  with
hronic  lymphocytic  disease.
iscussion
he  coexistence  of  HT  and  thyroid  cancer  has  been  reported
everal  times  in  literature.  Loh  et  al.  found  a  strong  associ-
tion  between  PTC  and  lymphocytic  thyroiditis6 --  a  ﬁnding
onsistent  with  other  studies.2,5,14--16 In  the  present  study,
he  prevalence  of  HT  associated  with  PTC  was  35.4%,  a
ate  similar  to  that  found  in  the  study  conducted  by  Kim
t  al.17 However,  its  inﬂuence  on  the  behavior  of  thy-
oid  carcinoma  is  still  a  matter  of  debate.  Some  studies
eported  a  worse  prognosis  among  cases  associated  with
hyroiditis.18,19 Other  investigations  found  a  similar  behavior
mong  cases  with  or  without  associated  thyroiditis.20 How-
ver,  the  majority  of  studies  showed  a  protective  effect  of
ymphocytic  disease.5,6,14,21--25 Kashima  et  al.  reported  mor-
ality  and  disease-free  interval  after  ten  years  of  5%  and  85%
mong  patients  without  associated  thyroiditis,  compared  to
.7%  and  95%  among  cases  with  association,  respectively.5
he  favorable  outcome  of  these  patients  suggests  that  the
ssociation  with  thyroiditis  may  represent  an  anti-tumor
esponse,26 although  it  is  not  clear  whether  the  coexis-
ence  of  both  diseases  is  not  simply  a greater  chance  for
 synchronous  occurrence  of  two  high-prevalence  diseases.
oh  et  al.  noted  that  the  association  with  HT  was  asso-
iated  with  lower  recurrence  and  mortality  rates.  In  that
tudy,  the  group  with  the  higher  recurrence  rate  showed  a
igher  frequency  of  lymph  node  metastases,  which  may  have
ontributed  greatly  to  the  rise  in  this  rate.  Even  with  the
aintenance  of  statistical  signiﬁcance  after  the  multivari-
te  analysis  of  the  association  with  good  prognosis  among
ases  affected  by  HT,  the  researchers  of  that  study  failed
o  elucidate  the  differences  in  aspects  related  to  treatment
etween  the  two  study  groups.  Moreover,  the  various  sub-
ypes  of  thyroid  lymphocytic  inﬁltrate  were  included.  No
ne  knows  the  exact  prognostic  inﬂuences  of  these  subtypes,
lthough  it  is  known  that  they  may  represent  the  spectrum
f  manifestations  of  chronic  lymphocytic  thyroiditis.6 These
ethodological  features  were  further  explored  in  the  study
y  Jeong  et  al.,  who  also  demonstrated  a  lower  recurrence
mong  cases  associated  with  HT.27 However,  both  in  that
tudy  and  in  others,  the  association  with  HT  did  not  func-
ion  as  an  independent  predictor  of  a  lower  recurrence  rate
fter  a multivariate  analysis.23,27
It  is  possible  that  the  better  prognosis  of  cases  associ-
ted  with  HT  simply  arises  from  an  association  with  other
actors  historically  recognized  for  better  prognoses,  as  has
een  observed  among  variants  or  tumor  histopathological
eatures.28 Kim  et  al.  found  a  higher  frequency  of  women,
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Table  1  Analysis  of  clinical  and  pathological  characteristics  according  to  the  presence  or  absence  of  Hashimoto  thyroiditis
among cases  of  papillary  thyroid  carcinoma.
Hashimoto  thyroiditis
Present Absent  Total p-Value
Mean  (SD)  Mean  (SD)  Mean  (SD)
Age  (years)  45.97  (14.10)  47.15  (14.14)  46.73  (14.12)  0.418
Tumor diameter  (cm)  1.40  (1.15)  1.91  (1.70)  1.73  (1.54)  --
Median (Min--Max)  Median  (Min--Max)  Median  (Min--Max)  p-Value
Tumor  diameter  1.2  (0.04--6.5)  1.3  (0.1--9)  1.2  (0.04--9)  0.007
n (148)  %  (35.4)  n  (269)  %  (64.5)  n  (417)  %  (100)  p-Value
Women/men  136/12  91.8/8.1  203/66  75.4/24.5  339/78  81.2/18.7  <0.001
Neurovascular  invasion  9  6.0  18  6.6  27  6.4  0.972
Multifocality  32  21.6  53  19.7  85  20.3  0.735
Multicentricity  54  36.4  78  28.9  132  31.6  0.143
Extracapsular  invasion  33  22.2  96  35.6  129  30.9  0.006
Lymphadenectomy  79  53.3  102  37.9  181  43.4  0.003
T stage
1 98  66.2  126  46.8  224  53.7
0.002
2 12  8.1  31  11.5  43  10.3
3 38  25.6  109  40.5  147  35.2
4 0  0  3  1.1  3  0.7
N stage
0 ou  X  115  77.7  200  74.3  315  75.5
0.2401a 23  15.5  37  13.7  60  14.3
1b 10  6.7  32  11.8  42  10.0
M stage
0 148  100  267  99.2  415  99.5
0.7551 0  0  2  0.7  2  0.4
Clinicopathological  staging
I 119  80.4  181  67.2  300  71.9
0.019
II 5  3.3  10  3.7  15  3.5
III 22  14.8  63  23.4  85  20.3
IV 2  1.3  15  5.5  17  4.0
n, absolute frequency; %, relative frequency; SD, standard deviation; Min--Max, variation between minimum and maximum; p-value,
level of signiﬁcance used; multifocality, refers to more than one tumor focus in the same lobe; multicentricity, refers to the presence
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ower  mean  tumor  diameter,  and  lower  mean  age  among
ases  associated  with  HT.23 However,  in  another  study,  a
igher  frequency  of  bilateral  disease  among  cases  associ-
ted  with  HT  was  found,  although  its  authors  noted  in  the
ame  patients,  a  greater  rate  of  total  thyroidectomy  than
n  the  control  group.17 The  present  study  observed  a  high
revalence  of  bilateral  disease  (31.6%),  preponderant  in  the
roup  associated  with  HT,  although  without  statistical  signif-
cance.  Similar  to  the  studies  of  Jeong  et  al.  and  Yoon  et  al.,
e  found  a  lower  mean  tumor  diameter  and  lower  rate  of
xtracapsular  invasion  among  cases  associated  with  HT.27,29
his  set  of  variables,  historically  recognized  by  different
rognostic  steps,  distinguish  PTC  cases  associated  with  HT
s  a  peculiar  pattern  of  disease  presentation.
Jeong  et  al.  observed  a  greater  number  of  lymph  nodes
esected  among  cases  undergoing  cervical  lymphadenec-
omy  in  the  group  associated  with  signs  of  HT.27 Similarly,
I
b
w
tur  study  found  a higher  rate  of  cervical  lymphadenectomy
mong  cases  associated  with  HT.  In  this  service,  cervical  lym-
hadenectomies  are  performed  only  for  cases  with  a  clinical
uspicion  of  PTC  or  with  metastatic  disease  suggested  by
maging  studies.  Since  the  rates  of  metastases  did  not  dif-
er  between  groups,  as  was  observed  by  Jeong  et  al.,  this
ay  suggest  that,  for  some  reason,  possibly  inﬂammatory
actors,  there  are  more  clinically  suspicious  lymph  nodes
mong  patients  with  a  diagnosis  of  HT.27
onclusionsn  this  study,  we  found  a  high  prevalence  of  association
etween  HT  and  PTC.  The  presence  of  HT  was  associated
ith  disease  presentation  at  an  earlier  stage  and  with  fac-
ors  historically  recognized  by  better  outcomes  at  the  time
es  
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of  surgery,  which  could  per  se  inﬂuence  the  prognosis  and
recurrence.  However,  to  date,  the  ﬁnding  of  an  association
of  HT  with  PTC  should  not  modify  the  medical  management;
rather,  this  ﬁnding  simply  should  draw  the  physician’s  atten-
tion  to  a  peculiar  pattern  of  disease  presentation.
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